Robert McDowell
67Patents
14h-index
91Co-inventors
87Inventor score
Filing activity: Apr 10, 1992 → Mar 19, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5532359A | Ras farnesyl transferase inhibitors | Human Necessities | 98 | Expired |
| US6271198A | Constrained helical peptides and methods of making same | Chemistry; Metallurgy | 74 | Expired |
| US5846932A | Receptor specific atrial natriuretic peptides | Human Necessities | 52 | Expired |
| US5665704A | Receptor specific atrial natriuretic peptides | Human Necessities | 45 | Expired |
| US6005117A | Imino compounds, process for their preparation and their use as victronectin antagonists | Human Necessities | 41 | Expired |
| US5493007A | Platelet aggregation inhibitors having high specificity for GPIIBIIIA | Emerging Cross-Sectional Technologies | 35 | Expired |
| US5843941A | Ras farnesyl transferase inhibitors | Human Necessities | 32 | Expired |
| US5565449A | Nonpeptidyl integrin inhibitors having specificity for the GPII.sub.b III.sub.a receptor | Chemistry; Metallurgy | 27 | Expired |
| US5798337A | Low molecular weight peptidomimetic growth hormone secretagogues | Human Necessities | 27 | Expired |
| US6525022B1 | Receptor specific atrial natriuretic peptides | Human Necessities | 26 | Expired |
| US5403836A | Benzazepine platelet aggregation inhibitors having specificity for the GPII.sub.b III.sub.a receptor | Chemistry; Metallurgy | 24 | Expired |
| US6660728B2 | Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists | Chemistry; Metallurgy | 19 | Expired |
| US6806279B2 | Small-molecule inhibitors of interleukin-2 | Human Necessities | 19 | Expired |
| US5250679A | Nonpeptidyl platelet aggregation inhibitors having specificity for the GPII.sub.b III.sub. receptor | Chemistry; Metallurgy | 16 | Expired |
| US6313119A | Sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion | Chemistry; Metallurgy | 14 | Expired |
| US6221907A | Tricyclic compounds having activity specific for integrins, particularly alphanubeta3 integrins, method for preparing same, intermediates therefor, use of said compounds as drugs, and pharmaceutical compositions containing same | Emerging Cross-Sectional Technologies | 14 | Expired |
| US9181200B2 | Pyrimidinedione compounds | Chemistry; Metallurgy | 13 | Active |
| US9199945B2 | Cycloalkyl-substituted pyrimidinedione compounds | Chemistry; Metallurgy | 12 | Active |
| US9925177B2 | 4-methylsulfonyl-substituted piperidine urea compounds | Chemistry; Metallurgy | 12 | Active |
| US8871790B2 | Heterocyclic modulators of lipid synthesis | Chemistry; Metallurgy | 12 | Active |
| US5674863A | Nonpeptidyl integrin inhibitors having specificity for the GPII.sub.b III.sub.a receptor | Chemistry; Metallurgy | 10 | Expired |
| US9663516B2 | Bicyclic-pyrimidinedione compounds | Chemistry; Metallurgy | 10 | Active |
| US5990145A | Vitronectin receptor antagonists, their preparation and their use | Human Necessities | 10 | Expired |
| US5663166A | Nonpeptidyl integrin inhibitors having specificity for the GPII.sub.b III.sub.a receptor | Chemistry; Metallurgy | 9 | Expired |
| US5674865A | Nonpeptidyl integrin inhibitors having specificity for the GPII.sub.b III.sub.a | Chemistry; Metallurgy | 8 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.